EP-31670

N/A

Report date: 2022/09/02 09:47:14
NME

Base Information

Drug NameEP-31670
Drug Alias NameNEO-2734EP-31670
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain-containing protein 4 inhibitorsp300-CBP transcription factors inhibitorsBromodomain and extra terminal domain protein inhibitors
Targetsp300-CBP transcription factorsBromodomain-containing protein 4Bromodomain and extra terminal domain protein
Therapy Area/IndicationsNUT midline carcinomaProstatic Neoplasms, Castration-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEpigenetixNeomed Institute
China Registration ClassN/A

Develop Information

Active CompaniesEpigenetix
Inactive CompaniesN/A
Active IndicationsNUT midline carcinomaProstatic Neoplasms, Castration-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A